×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share
6935 views

Moderators : Anna Fagotti & Gwenaël Ferron

Agenda

  Introduction
Anna Fagotti & Gwenaël Ferron
 
  HIPEC in first setting
Willemien Van Driel
 
  HIPEC in recurrent disease
Jean-Marc Classe
 
  Oncologic issues
Laurence Gladieff
 
  Take home message
Anna Fagotti
 

 

Shooting date : 2024-02-06
Last update : 2024-04-03
2 comments
Join the Discussion
  • ANIK G. Can't wait to see this webinar. Wonderful and much anticipated topic.

      Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
      Your browser doesn't have Flash, Silverlight or HTML5 support.


    • Gwenaël F. Dear Anik. The VOD is available !!

        Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
        Your browser doesn't have Flash, Silverlight or HTML5 support.


      Suggestions

      Wednesday, January 22nd 2025 from 06pm to 07pm (GMT+1)
      Honolulu : Wednesday, January 22nd 2025 from 06am to 07am (GMT+1)
      San Francisco : Wednesday, January 22nd 2025 from 08am to 09am (GMT+1)
      New York : Wednesday, January 22nd 2025 from 11am to 12pm (GMT+1)
      Buenos Aires : Wednesday, January 22nd 2025 from 01pm to 02pm (GMT+1)
      London / Dublin : Wednesday, January 22nd 2025 from 04pm to 05pm (GMT+1)
      Paris / Berlin : Wednesday, January 22nd 2025 from 05pm to 06pm (GMT+1)
      Istanbul : Wednesday, January 22nd 2025 from 06pm to 07pm (GMT+1)
      Moscou / Dubaï : Wednesday, January 22nd 2025 from 08pm to 09pm (GMT+1)
      Bangkok : Wednesday, January 22nd 2025 from 11pm to 12am (GMT+1)
      Shanghai : Thursday, January 23rd 2025 from 12am to 01am (GMT+1)
      Tokyo : Thursday, January 23rd 2025 from 01am to 02am (GMT+1)
      Sydney : Thursday, January 23rd 2025 from 02am to 03am (GMT+1)
      Wellington : Thursday, January 23rd 2025 from 04am to 05am (GMT+1)

      Prise en charge des cancers de l'ovaire en rechute :

      état des lieux et perspectives

      Share
      Tuesday, April 15th 2025 from 06pm to 07:30pm (GMT+2)
      Honolulu : Tuesday, April 15th 2025 from 06am to 07:30am (GMT+2)
      San Francisco : Tuesday, April 15th 2025 from 09am to 10:30am (GMT+2)
      New York : Tuesday, April 15th 2025 from 12pm to 01:30pm (GMT+2)
      Buenos Aires : Tuesday, April 15th 2025 from 01pm to 02:30pm (GMT+2)
      Reykjavik : Tuesday, April 15th 2025 from 04pm to 05:30pm (GMT+2)
      London / Dublin : Tuesday, April 15th 2025 from 05pm to 06:30pm (GMT+2)
      Paris / Berlin : Tuesday, April 15th 2025 from 06pm to 07:30pm (GMT+2)
      Istanbul : Tuesday, April 15th 2025 from 07pm to 08:30pm (GMT+2)
      Moscou / Dubaï : Tuesday, April 15th 2025 from 08pm to 09:30pm (GMT+2)
      Bangkok : Tuesday, April 15th 2025 from 11pm to 12:30am (GMT+2)
      Shanghai : Wednesday, April 16th 2025 from 12am to 01:30am (GMT+2)
      Tokyo : Wednesday, April 16th 2025 from 01am to 02:30am (GMT+2)
      Sydney : Wednesday, April 16th 2025 from 03am to 04:30am (GMT+2)
      Wellington : Wednesday, April 16th 2025 from 05am to 06:30am (GMT+2)

      Outils utiles aux cliniciens durant la chimio néoadjuvante des cancers de l’ovaire

      Share
      Wednesday, May 21st 2025 from 06pm to 07pm (GMT+2)
      Honolulu : Wednesday, May 21st 2025 from 06am to 07am (GMT+2)
      San Francisco : Wednesday, May 21st 2025 from 09am to 10am (GMT+2)
      New York : Wednesday, May 21st 2025 from 12pm to 01pm (GMT+2)
      Buenos Aires : Wednesday, May 21st 2025 from 01pm to 02pm (GMT+2)
      Reykjavik : Wednesday, May 21st 2025 from 04pm to 05pm (GMT+2)
      London / Dublin : Wednesday, May 21st 2025 from 05pm to 06pm (GMT+2)
      Paris / Berlin : Wednesday, May 21st 2025 from 06pm to 07pm (GMT+2)
      Istanbul : Wednesday, May 21st 2025 from 07pm to 08pm (GMT+2)
      Moscou / Dubaï : Wednesday, May 21st 2025 from 08pm to 09pm (GMT+2)
      Bangkok : Wednesday, May 21st 2025 from 11pm to 12am (GMT+2)
      Shanghai : Thursday, May 22nd 2025 from 12am to 01am (GMT+2)
      Tokyo : Thursday, May 22nd 2025 from 01am to 02am (GMT+2)
      Sydney : Thursday, May 22nd 2025 from 03am to 04am (GMT+2)
      Wellington : Thursday, May 22nd 2025 from 05am to 06am (GMT+2)

      16e congrès de la SFCO

      Carcinose

      Share
      Wednesday, January 31st 2024 from 06pm to 07:30pm (GMT+1)
      Honolulu : Wednesday, January 31st 2024 from 06am to 07:30am (GMT+1)
      San Francisco : Wednesday, January 31st 2024 from 08am to 09:30am (GMT+1)
      New York : Wednesday, January 31st 2024 from 11am to 12:30pm (GMT+1)
      Buenos Aires : Wednesday, January 31st 2024 from 01pm to 02:30pm (GMT+1)
      London / Dublin : Wednesday, January 31st 2024 from 04pm to 05:30pm (GMT+1)
      Paris / Berlin : Wednesday, January 31st 2024 from 05pm to 06:30pm (GMT+1)
      Istanbul : Wednesday, January 31st 2024 from 06pm to 07:30pm (GMT+1)
      Moscou / Dubaï : Wednesday, January 31st 2024 from 08pm to 09:30pm (GMT+1)
      Bangkok : Wednesday, January 31st 2024 from 11pm to 12:30am (GMT+1)
      Shanghai : Thursday, February 1st 2024 from 12am to 01:30am (GMT+1)
      Tokyo : Thursday, February 1st 2024 from 01am to 02:30am (GMT+1)
      Sydney : Thursday, February 1st 2024 from 02am to 03:30am (GMT+1)
      Wellington : Thursday, February 1st 2024 from 04am to 05:30am (GMT+1)

      KELIM ou comment optimiser l’utilisation du CA 125 dans la prise en charge du cancer de l’ovaire...

      Share
      Scroll Up